JPMorgan Chase Has Raised Its Dividend for 14 Years Running. Is It the Best Dividend Stock in Banking?

JPMorgan Chase extended its dividend-growth streak with two increases in 2025, taking the year-to-date dividend up 20%, while Q1 2026 revenue rose 13% and EPS increased 17% year over year. The stock screens as fundamentally strong but relatively expensive at 2.3x price-to-book versus its five-year average of about 1.8x, with a 2.0% yield below the 2.3% bank average. The article frames JPMorgan as a solid dividend-growth name, but suggests income-focused investors may prefer Bank of Nova Scotia's 4.1% yield.

Analysis

The market is rewarding JPM for consistency, but the setup is increasingly a quality premium trade rather than a cheap compounding story. At ~2.3x book, the stock is effectively pricing in a prolonged period of above-trend ROE and benign credit, which leaves less room for multiple expansion if rate cuts steepen the curve or loan growth softens. In other words, the upside from another dividend hike is mathematically small relative to the valuation compression risk if earnings merely normalize.

The more interesting second-order effect is relative value within banking: JPM has become the default “safe bank,” which can cap its yield and push income capital into names with lower perceived franchise quality but higher cash return. That supports BNS as the contrarian yield alternative, but also creates a lagged opportunity in BAC if investors begin rotating away from the premium franchise into cheaper balance-sheet beta once rate volatility declines. If the market starts treating bank dividends as a yield-arbitrage screen rather than a quality screen, JPM is the least attractive of the three on forward income-adjusted return.

The main catalyst to watch is whether the next 1-2 quarters show earnings durability broad enough to justify the premium multiple, or whether the current enthusiasm is already forward-loaded. The bear case is not a credit event; it’s multiple compression from a disappointment in net interest income, capital markets, or loan growth, which could matter quickly over days to weeks. The bull case needs either a re-acceleration in capital markets fees or a sustained buyback/dividend cadence that overwhelms valuation concerns over the next 6-12 months.

Consensus is missing that JPM’s dividend story is now mostly about signaling, not yield. For true income investors, the better risk/reward may be in higher-yield, lower-multiple banks where the market has already discounted the scar tissue. The trade is less about picking the best bank and more about avoiding overpaying for the best narrative.

Key Decisions for Investors

• Trim JPM into strength over the next 1-3 weeks; hold only if you are explicitly underwriting continued ROE expansion. Risk/reward is asymmetric below the current premium if earnings normalize.
• Initiate a relative-value pair: long BNS / short JPM for 3-6 months. The thesis is yield compression on JPM versus higher cash return in BNS; target mean reversion in the dividend-adjusted total return spread.
• Consider a cheaper-bank basket long BAC vs short JPM for 1-2 quarters if the next print shows stable credit and modest loan growth. BAC has more room for multiple rerating from a depressed base, while JPM has less valuation upside.
• For dividend-focused mandates, sell cash-secured puts on BNS 3-6 months out to monetize elevated yield while defining entry. Reward is premium capture plus a lower-cost basis if the stock pulls back.
• Avoid chasing JPM ahead of the next earnings cycle unless the position is paired with a hedge on bank multiples. The stock can de-rate 10-15% on a small miss because the valuation already embeds a lot of good news.